Document is current
Any future updates will be listed below
-
Authors
Hu, Tianyan
Song, Yan
Done, Nicolae
Liu, Qing
Sarpong, Eric M.
Lemus-Wirtz, Esteban
Signorovitch, James
Mohanty, Salini
Weiss, Thomas
-
Funding
Funding for this research was provided by:
Merck & Co., Inc.
- License Information
-
More Information
Article History
Received: 11 January 2022
Accepted: 17 August 2022
First Online: 5 September 2022
Declarations
:
: This study involved de-identified, aggregate data from a pre-existing dataset that was licensed to Merck & Co., Inc., and was not subject to Institutional Review Board approval at Merck & Co., Inc. or Analysis Group, Inc. Informed consent was not needed as all patients were anonymized and only aggregate data are reported here. A research review committee at Merck & Co., Inc. approved the study protocol prior to the study initiation. All methods were performed in accordance with the relevant guidelines and regulations, including the principles of the Declaration of Helsinki.
: Not applicable.
: TH, SM, ES, and TW are employees of Merck & Co., Inc. and may own stock/stock options.ND, YS, QL, ELW, and JS are employees of Analysis Group, Inc., a consulting firm that received funding from Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Rahway, NJ USA to conduct this study.
